Burn Scar Appearance After Treatment With Fractional Carbon Dioxide (CO2) Laser

This study has been completed.
Sponsor:
Information provided by:
Moy-Fincher Medical Group
ClinicalTrials.gov Identifier:
NCT00969215
First received: August 29, 2009
Last updated: July 24, 2011
Last verified: July 2011
  Purpose

The purpose of this study is to determine if fractional carbon dioxide laser treatment of a burn scar is a more effective method for improving the appearance of scars than the current available treatments.


Condition Intervention
Scars
Device: Lumenis fractional carbon dioxide laser

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Burn Scar Characteristics After Treatment With Fractional CO2 Laser: A Clinical and Histological Study

Resource links provided by NLM:


Further study details as provided by Moy-Fincher Medical Group:

Primary Outcome Measures:
  • Evidence of clinical improvement of burn scar appearance as determined by blinded-observer and patient ratings. [ Time Frame: 2 weeks after each procedure ] [ Designated as safety issue: No ]

Estimated Enrollment: 20
Study Start Date: December 2009
Study Completion Date: December 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Laser treatment
Half of each subject's scar will be treated with a fractional CO2 laser.
Device: Lumenis fractional carbon dioxide laser
Laser resurfacing of a burn scar
Other Name: Lumenis
No Intervention: No treatment
Half of each subject's scar will not be treated.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Have a mature burn scar and desire revision
  • Fluent in English
  • Must reside in the Los Angeles vicinity for the duration of the study

Exclusion Criteria:

  • Previous history of scar revision
  • Non-English speakers
  • Pregnant or cognitively impaired subjects
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00969215

Locations
United States, California
Moy-Fincher Medical Group
Los Angeles, California, United States, 90095
Sponsors and Collaborators
Moy-Fincher Medical Group
Investigators
Principal Investigator: David Ozog, MD Moy-Fincher Medical Group
  More Information

No publications provided

Responsible Party: Ronald Moy, MD, Moy-Fincher Medical Group
ClinicalTrials.gov Identifier: NCT00969215     History of Changes
Other Study ID Numbers: MF-02
Study First Received: August 29, 2009
Last Updated: July 24, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Moy-Fincher Medical Group:
burn scar
fractional carbon dioxide laser
scar revision

ClinicalTrials.gov processed this record on October 16, 2014